COSMOS Pharmaceutical Corporation (3349.T)

Better than 9843.T's revenue of 895.80B.

Better than 9843.T's revenue growth rate of 10.23%.

Better than 9843.T's depreciation of 29.67B.

Better than 9843.T's receivables of 79.25B.

Better than 9843.T's receivables as percentage of revenue of 8.85%.

Better than 9843.T's inventories of 108.53B.

Better than 9843.T's inventories as percentage of revenue of 12.12%.

Better than 9843.T's weighted average cost of capital (wacc) of 6.71%.

Better than 9843.T's cost of equity of 7.20%.

Better than 9843.T's beta of 0.68.

Better than 9843.T's diluted shares outstanding of 113.01M.

Better than 9843.T's total debt of 203.02B.

Better than 9843.T's debt weighting of 11.14%.

Better than 9843.T's equity weighting of 88.86%.

Better than 9843.T's long-term growth rate of 1.00%.

Better than 9843.T's net debt of 41.10B.

Better than 9843.T's equity value of 343.04B.

Better than 9843.T's equity value per share of 3035.43.